S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
NVDA   195.61 (-0.20%)
MU   44.66 (-1.24%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
NVDA   195.61 (-0.20%)
MU   44.66 (-1.24%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
Log in

Collegium Pharmaceutical SEC Filings & 10K Form (NASDAQ:COLL)

$11.42
-0.45 (-3.79 %)
(As of 10/22/2019 04:00 PM ET)
Today's Range
$11.41
Now: $11.42
$11.97
50-Day Range
$10.52
MA: $11.54
$12.81
52-Week Range
$10.01
Now: $11.42
$19.83
Volume309,356 shs
Average Volume355,426 shs
Market Capitalization$382.24 million
P/E RatioN/A
Dividend YieldN/A
Beta0.52

SEC Filings

Collegium Pharmaceutical (NASDAQ:COLL) SEC Filings

DateFilerForm TypeView
09/18/2019
3:06 PM
Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2019
5:16 PM
Collegium Pharmaceutical (Issuer)
Hirsch David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2019
3:47 PM
Collegium Pharmaceutical (Issuer)
Fleming Alison B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2019
3:46 PM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2019
3:45 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
4:02 PM
Collegium Pharmaceutical (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/07/2019
3:03 PM
Collegium Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2019
3:01 PM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2019
3:04 PM
Collegium Pharmaceutical (Issuer)
Fleming Alison B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2019
3:03 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2019
3:02 PM
Brannelly Paul (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2019
3:22 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2019
3:08 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
5:15 PM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
5:05 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
3:17 PM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
3:04 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
3:03 PM
Collegium Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2019
3:02 PM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
3:00 PM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
7:52 AM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
5:55 PM
Collegium Pharmaceutical (Issuer)
Fallon John A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
5:52 PM
Collegium Pharmaceutical (Issuer)
Schroeder Theodore R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
5:50 PM
Collegium Pharmaceutical (Issuer)
Hirsch David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
5:48 PM
Collegium Pharmaceutical (Issuer)
Freund John Gordon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
5:44 PM
Collegium Pharmaceutical (Issuer)
SANTINI GINO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
5:42 PM
BOHLIN GAREN G (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
5:39 PM
Collegium Pharmaceutical (Issuer)
Melincoff Gwen A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2019
3:24 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
3:12 PM
Collegium Pharmaceutical (Issuer)
Malamut Richard (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/19/2019
4:41 PM
Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
4:36 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2019
3:01 PM
Collegium Pharmaceutical (Filer)
Form DEF 14A
02/27/2019
3:01 PM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
2:39 PM
Collegium Pharmaceutical (Subject)
MACQUARIE GROUP LTD (Filed by)
Form SC 13G
02/14/2019
10:07 AM
Collegium Pharmaceutical (Subject)
Rock Springs Capital Management LP (Filed by)
Form SC 13G/A
02/12/2019
4:12 PM
Collegium Pharmaceutical (Subject)
Longitude Capital Partners, LLC (Filed by)
Form SC 13G/A
02/12/2019
8:14 AM
Collegium Pharmaceutical (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
02/11/2019
4:06 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2019
4:03 PM
Collegium Pharmaceutical (Issuer)
Fleming Alison B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2019
9:22 AM
BlackRock Inc. (Filed by)
Collegium Pharmaceutical (Subject)
Form SC 13G/A
01/29/2019
3:46 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
3:42 PM
Collegium Pharmaceutical (Issuer)
Fleming Alison B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
3:39 PM
Brannelly Paul (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
3:37 PM
Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
3:33 PM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
2:30 PM
Collegium Pharmaceutical (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SC 13G
01/23/2019
3:17 PM
Collegium Pharmaceutical (Issuer)
Fleming Alison B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
3:14 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
3:13 PM
Brannelly Paul (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2019
3:16 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
7:00 AM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2018
4:09 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2018
4:05 PM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2018
3:19 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2018
3:16 PM
Collegium Pharmaceutical (Issuer)
Freund John Gordon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2018
10:27 AM
Collegium Pharmaceutical (Filer)
Form D
Notice of Exempt Offering of Securities 
11/08/2018
3:06 PM
Collegium Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2018
3:06 PM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2018
3:27 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2018
3:07 PM
Brannelly Paul (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2018
3:06 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2018
3:04 PM
Collegium Pharmaceutical (Issuer)
Fleming Alison B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2018
3:03 PM
Collegium Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2018
3:01 PM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2018
4:43 PM
Brannelly Paul (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2018
4:41 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2018
4:39 PM
Collegium Pharmaceutical (Issuer)
Fleming Alison B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2018
3:41 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2018
3:38 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/02/2018
4:44 PM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2018
5:25 PM
Brannelly Paul (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2018
3:58 PM
Collegium Pharmaceutical (Issuer)
Fleming Alison B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2018
3:56 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2018
3:09 PM
Collegium Pharmaceutical (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/04/2018
5:00 PM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
3:01 PM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2018
4:08 PM
Collegium Pharmaceutical (Issuer)
Fallon John A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2018
4:07 PM
Collegium Pharmaceutical (Issuer)
Schroeder Theodore R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2018
4:06 PM
Collegium Pharmaceutical (Issuer)
Melincoff Gwen A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2018
4:05 PM
BOHLIN GAREN G (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2018
4:04 PM
Collegium Pharmaceutical (Issuer)
Freund John Gordon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2018
4:02 PM
Collegium Pharmaceutical (Issuer)
Hirsch David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2018
4:01 PM
Collegium Pharmaceutical (Issuer)
SANTINI GINO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2018
3:01 PM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2018
3:32 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2018
3:07 PM
Collegium Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2018
3:03 PM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2018
4:05 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/13/2018
7:26 AM
Collegium Pharmaceutical (Filer)
Form DEFA14A
04/13/2018
7:22 AM
Collegium Pharmaceutical (Filer)
Form DEF 14A
04/05/2018
4:00 PM
Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2018
3:50 PM
Collegium Pharmaceutical (Issuer)
Fleming Alison B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2018
3:05 PM
Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/21/2018
6:58 PM
Collegium Pharmaceutical (Issuer)
Freund John Gordon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2018
4:13 PM
Collegium Pharmaceutical (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2018
3:01 PM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2018
3:04 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2018
3:03 PM
Brannelly Paul (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2018
3:03 PM
Collegium Pharmaceutical (Issuer)
Fleming Alison B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 10/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel